Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in the Treatment of Major Depressive Disorders

PHASE3CompletedINTERVENTIONAL
Enrollment

310

Participants

Timeline

Start Date

April 30, 2006

Study Completion Date

May 31, 2007

Conditions
Major Depressive Disorder
Interventions
DRUG

Quetiapine fumarate

Trial Locations (34)

Unknown

Research Site, Phoenix

Research Site, Little Rock

Research Site, Anaheim

Research Site, El Centro

Research Site, Garden Grove

Research Site, National City

Research Site, Riverside

Research Site, Hartford

Research Site, Wilmington

Research Site, Altamonte Springs

Research Site, DeLand

Research Site, Maitland

Research Site, New Port Richey

Research Site, Atlanta

Research Site, Decatur

Research Site, Roswell

Research Site, Naperville

Research Site, Indianapolis

Research Site, Lafayette

Research Site, Owensboro

Research Site, New Orleans

Research Site, Braintree

Research Site, Cambridge

Research Site, Pittsfield

Research Site, Minneapolis

Research Site, St Louis

Research SIte, Staten Island

Research Site, Avon Lake

Research Site, Cincinnati

Research Site, Oklahoma City

Research Site, Allentown

Research Site, Memphis

Research Site, DeSoto

Research Site, Houston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY